National Bank of Canada
EDIT icon

National Bank of Canada’s Editas Medicine EDIT Stock Holding History

National Bank of Canada’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$4.49K – 2747
2022
Q4 		$4.49K Hold
5
– – ﹤0.01% 2351
2022
Q3 		$6K Hold
5
– – ﹤0.01% 2301
2022
Q2 		$6K Hold
5
– – ﹤0.01% 2377
2022
Q1 		$10K Hold
5
– – ﹤0.01% 2381
2021
Q4 		$13K Buy
+5
New +$172 ﹤0.01% 2268

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

National Bank of Canada's EDIT Position: Q2 2026 in Review

National Bank of Canada increased its Editas Medicine (EDIT) stake by 1.7% in Q2 2026, buying an estimated $123 and bringing the position to 2,542 shares worth $8.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2463.

National Bank of Canada first reported a position in EDIT in Q4 2021 and has held it in 16 quarters since. The position peaked at $22.9K in Q4 2023. 86 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • National Bank of Canada held 2,542 shares of Editas Medicine worth $8.24K as of Q2 2026.
  • National Bank of Canada bought 42 Editas Medicine shares in Q2 2026, an estimated $123.
  • Editas Medicine made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2463 holding.
  • National Bank of Canada first reported a position in Editas Medicine in Q4 2021 and has held it in 16 quarters since.
  • National Bank of Canada's Editas Medicine position peaked at $22.9K in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.